The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Open accessAbstract
Tuberculosis, a major health problem in developing countries, has reemerged in recent years in many industrialized countries. The increased susceptibility of immunocompromised individuals to tuberculosis, and many experimental studies indicate that T cell-mediated immunity plays an important role in resistance. The lymphokine interferon gamma (IFN-gamma) is thought to be a principal mediator of macrophage activation and resistance to intracellular pathogens. Mice have been developed which fail to produce IFN-gamma (gko), because of a targeted disruption of the gene for IFN-gamma. Upon infection with Mycobacterium tuberculosis, although they develop granulomas, gko mice fail to produce reactive nitrogen intermediates and are unable to restrict the growth of the bacilli. In contrast to control mice, gko mice exhibit heightened tissue necrosis and succumb to a rapid and fatal course of tuberculosis that could be delayed, but not prevented, by treatment with exogenous recombinant IFN-gamma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Self-citationCloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Self-citationDisease Control Priorities in Developing Countries
Mosley, W. H. (1993) · World Bank, Washington, DC eBooks · doi:10.1596/0-1952-0990-7 · Cited by 1,400
A TH1→TH2 switch is a critical step in the etiology of HIV infection
Clerici, M., & Shearer, G. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90208-3 · Cited by 1,390
Stuehr, D. J., & Marletta, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7738 · Cited by 1,126
Chan, J., Xing, Y., Magliozzo, R. S., & Bloom, B. R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1111 · Cited by 1,062
Self-citationLyons, C. R., Orloff, G. J., & Cunningham, J. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42704-4 · Cited by 864
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.
Liew, F. Y., Millott, S., Parkinson, C., Palmer, R. M. J., & Moncada, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4794 · Cited by 736
Cited by
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Self-citationDisseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Self-citationFlynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Self-citationT-cell quality in memory and protection: implications for vaccine design
Seder, R. A., Darrah, P. A., & Roederer, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2274 · Cited by 1,548
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,378
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,199
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,162
Mycobacterial persistence requires the utilization of host cholesterol
Pandey, A. K., & Sassetti, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711159105 · Cited by 1,064
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi, S., Revy, P., Emile, J.-F., Newport, M., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 895
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 883
Revisiting the role of the granuloma in tuberculosis
Ramakrishnan, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3211 · Cited by 883
Designing of interferon-gamma inducing MHC class-II binders
Dhanda, S. K., Vir, P., & Raghava, G. P. (2013) · Biology Direct · doi:10.1186/1745-6150-8-30 · Cited by 837
Medium- and Large-Vessel Vasculitis
Weyand, C. M., & Goronzy, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022694 · Cited by 788
The role of HIF in immunity and inflammation
McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
CD8+ T Cell Effector Mechanisms in Resistance to Infection
Harty, J. T., Tvinnereim, A. R., & White, D. W. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.275 · Cited by 726
Cooper, A. M., Magram, J., Ferrante, J., & Orme, I. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.39 · Cited by 715
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
North, R. J., & Jung, Y.-J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 629
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
Billiau, A., & Matthys, P. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.849 · Cited by 617
Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases
Kak, G., Raza, M., & Tiwari, B. K. (2018) · Biomolecular Concepts · doi:10.1515/bmc-2018-0007 · Cited by 617
Immune evasion and provocation by Mycobacterium tuberculosis
Chandra, P., Grigsby, S. J., & Philips, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00763-4 · Cited by 614
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R., Shellito, J. E., Bagby, G. J., Nelson, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050193 · Cited by 605
Vidal, S., Tremblay, M. L., Govoni, G., Gauthier, S., Sebastiani, G., Malo, D., Skamene, E., Olivier, M., Jothy, S., & Gros, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.655 · Cited by 603
Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601
Innate Immunity to Mycobacterium tuberculosis
van Crevel, R., Ottenhoff, T. H. M., & van der Meer, J. W. M. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.294-309.2002 · Cited by 598
Persistent bacterial infections: the interface of the pathogen and the host immune system
Monack, D. M., Mueller, A., & Falkow, S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro955 · Cited by 572
Davis, J. M., Clay, H., Lewis, J. L., Ghori, N., Herbomel, P., & Ramakrishnan, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00475-2 · Cited by 565
Mogues, T., Goodrich, M. E., Ryan, L., LaCourse, R., & North, R. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.271 · Cited by 558
Wolf, A. J., Linas, B., Trevejo-Nuñez, G. J., Kincaid, E., Tamura, T., Takatsu, K., & Ernst, J. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2509 · Cited by 557
Mohan, V. P., Scanga, C. A., Yu, K., Scott, H. M., Tanaka, K. E., Tsang, E., Tsai, M. C., Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1847-1855.2001 · Cited by 536
Self-citationM. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Vaccination against tuberculosis by DNA injection
Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., & Lowrie, D. B. (1996) · Nature Medicine · doi:10.1038/nm0896-888 · Cited by 506
Blackwell, J. M., Jamieson, S. E., & Burgner, D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-08 · Cited by 505
Tuberculosis: Latency and Reactivation
Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4195-4201.2001 · Cited by 500
Self-citationInducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
Nicholson, S., Bonecini-Almeida, M. D. G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2293 · Cited by 496
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O'Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 472
Interferon‐γ confers resistance to experimental allergic encephalomyelitis
Krakowski, M., & Owens, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260735 · Cited by 471
Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G., & Nathan, C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1123 · Cited by 459
Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R., & Andersen, P. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.672-678.2002 · Cited by 453
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
Escobar, L. E., Molina-Cruz, A., & Barillas-Mury, C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008410117 · Cited by 437
Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors
Harding, C. V., & Boom, W. H. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2321 · Cited by 435
Stanley, S. A., Johndrow, J. E., Manzanillo, P., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 432
Dorman, S. E., & Holland, S. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2901 · Cited by 429
Lindenstrøm, T., Agger, E. M., Korsholm, K. S., Darrah, P. A., Aagaard, C., Seder, R. A., Rosenkrands, I., & Andersen, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801592 · Cited by 421
Zhao, Z., Fux, B., Goodwin, M., Dunay, I. R., Strong, D., Miller, B. C., Cadwell, K., Delgado, M. A., Ponpuak, M., Green, K. G., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.003 · Cited by 419
Caruso, A. M., Serbina, N., Klein, E., Triebold, K., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
Self-citationInterferon-γ: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.004 · Cited by 412
Specific immunity to listeria monocytogenes in the absence of IFNγ
Harty, J. T., & Bevant, M. J. (1995) · Immunity · doi:10.1016/1074-7613(95)90163-9 · Cited by 411
Scriba, T. J., Kalsdorf, B., Abrahams, D.-A., Isaacs, F., Hofmeister, J., Black, G., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1962 · Cited by 410
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
Chan, J., Tanaka, K., Carroll, D., Flynn, J., & Bloom, B. R. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.736-740.1995 · Cited by 407
Self-citationWSX-1 is required for the initiation of Th1 responses and resistance to L. major infection
Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00206-0 · Cited by 406
Cytokines and Chemokines in Mycobacterium tuberculosis Infection
Domingo-Gonzalez, R., Prince, O., Cooper, A., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 404
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Tufariello, J. M., Chan, J., & Flynn, J. L. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00741-2 · Cited by 403
Self-citationKagina, B. M. N., Abel, B., Scriba, T. J., Hughes, E. J., Keyser, A., Soares, A., Gamieldien, H., Sidibana, M., Hatherill, M., Gelderbloem, S., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0334oc · Cited by 402
IL-10–producing T cells suppress immune responses in anergic tuberculosis patients
Boussiotis, V. A., Tsai, E. Y., Yunis, E. J., Thim, S., Delgado, J. C., Dascher, C. C., Berezovskaya, A., Rousset, D., Reynes, J.-M., & Goldfeld, A. E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9918 · Cited by 398
Tiberi, S., du Plessis, N., Walzl, G., Vjecha, M. J., Rao, M., Ntoumi, F., Mfinanga, S., Kapata, N., Mwaba, P., McHugh, T. D., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30110-5 · Cited by 396
SALMONELLOSIS: Host Immune Responses and Bacterial Virulence Determinants1
Jones, B. D., & Falkow, S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.533 · Cited by 385
Jouanguy, E., Lamhamedi-Cherradi, S., Altare, F., Fondanèche, M. C., Tuerlinckx, D., Blanche, S., Emile, J. F., Gaillard, J. L., Schreiber, R., Levin, M., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119810 · Cited by 377
Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection
Nandi, B., & Behar, S. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110919 · Cited by 374
Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing
Zhang, Y. J., Reddy, M. C., Ioerger, T. R., Rothchild, A. C., Dartois, V., Schuster, B. M., Trauner, A., Wallis, D., Galaviz, S., Huttenhower, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.045 · Cited by 351
“…shown that the Th1 subset is especially effective in limiting Mtb growth, and cytokines such as IFN-g and TNF-a are needed in some, but not all, models of CD4 T cell-mediated defenses (Bold et al., 2011; Flynn et al., 1993, 1995; Gallegos et al., 2011; Nandi and Behar, 2011; Scanga et al., 2000).”
A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis
Vandal, O. H., Pierini, L. M., Schnappinger, D., Nathan, C. F., & Ehrt, S. (2008) · Nature Medicine · doi:10.1038/nm.1795 · Cited by 368
Hodgson, K., Morris, J., Bridson, T., Govan, B., Rush, C., & Ketheesan, N. (2015) · Immunology · doi:10.1111/imm.12394 · Cited by 367
Control of latentMycobacterium tuberculosis infection is dependent on CD8 T cells
van Pinxteren, L. A. H., Cassidy, J. P., Smedegaard, B. H. C., Agger, E. M., & Andersen, P. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12<3689::aid-immu3689>3.0.co;2-4 · Cited by 366
Abel, B., Thieblemont, N., Quesniaux, V. J. F., Brown, N., Mpagi, J., Miyake, K., Bihl, F., & Ryffel, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3155 · Cited by 363
Human cytolytic and interferon γ-secreting CD8+T lymphocytes specific for Mycobacterium tuberculosis
Lalvani, A., Brookes, R., Wilkinson, R. J., Malin, A. S., Pathan, A. A., Andersen, P., Dockrell, H., Pasvol, G., & Hill, A. V. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.270 · Cited by 361
Lethal tuberculosis in interleukin-6-deficient mutant mice
Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M., & Kaufmann, S. H. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4843-4849.1997 · Cited by 358
Effects of cytokines on mycobacterial phagosome maturation
Via, L. E., Fratti, R. A., McFalone, M., Pagán-Ramos, E., Deretic, D., & Deretic1, V. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.7.897 · Cited by 356
Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline
Glickman, M. S., & Jacobs, W. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00236-7 · Cited by 352
Pathan, A. A., Wilkinson, K. A., Klenerman, P., McShane, H., Davidson, R. N., Pasvol, G., Hill, A. V. S., & Lalvani, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5217 · Cited by 351
Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7099-7108.2003 · Cited by 350
Scanga, C. A., Mohan, V. P., Yu, K., Joseph, H., Tanaka, K., Chan, J., & Flynn, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.347 · Cited by 350
Self-citationVordermeier, H. M., Chambers, M. A., Cockle, P. J., Whelan, A. O., Simmons, J., & Hewinson, R. G. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3026-3032.2002 · Cited by 349
Day, C. L., Abrahams, D. A., Lerumo, L., Janse van Rensburg, E., Stone, L., O’rie, T., Pienaar, B., de Kock, M., Kaplan, G., Mahomed, H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101122 · Cited by 346
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis
Kramnik, I., Dietrich, W. F., Demant, P., & Bloom, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150227197 · Cited by 345
Self-citationInterferon-γ and interleukin-12 pathway defects and human disease
Dorman, S. E., & Holland, S. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00010-1 · Cited by 336
The role of gamma interferon in antimicrobial immunity
Shtrichman, R., & Samuel, C. E. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00199-5 · Cited by 334
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., & Bramwell, V. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.036 · Cited by 333
Green, A. M., DiFazio, R., & Flynn, J. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200061 · Cited by 328
Self-citationRole of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis
Cavalcanti, Y. V. N., Brelaz, M. C. A., Lemoine Neves, J. K. D. A., Ferraz, J. C., & Pereira, V. R. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/745483 · Cited by 324
Aptamer-Based Electrochemical Biosensor for Interferon Gamma Detection
Liu, Y., Tuleouva, N., Ramanculov, E., & Revzin, A. (2010) · Analytical Chemistry · doi:10.1021/ac101409t · Cited by 324
Confronting the scientific obstacles to global control of tuberculosis
Young, D. B., Perkins, M. D., Duncan, K., & Barry, C. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34614 · Cited by 324
Brodin, P., Majlessi, L., Marsollier, L., de Jonge, M. I., Bottai, D., Demangel, C., Hinds, J., Neyrolles, O., Butcher, P. D., Leclerc, C., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.1.88-98.2006 · Cited by 318
Werninghaus, K., Babiak, A., Groß, O., Hölscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H., Finger, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081445 · Cited by 315
In search of a new paradigm for protective immunity to TB
Nunes-Alves, C., Booty, M. G., Carpenter, S. M., Jayaraman, P., Rothchild, A. C., & Behar, S. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3230 · Cited by 315
Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection
Simmons, J. D., Stein, C. M., Seshadri, C., Campo, M., Alter, G., Fortune, S., Schurr, E., Wallis, R. S., Churchyard, G., Mayanja-Kizza, H., et al. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0025-3 · Cited by 314
Skeiky, Y. A. W., Alderson, M. R., Ovendale, P. J., Guderian, J. A., Brandt, L., Dillon, D. C., Campos-Neto, A., Lobet, Y., Dalemans, W., Orme, I. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7618 · Cited by 313
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 312
Immunology of tuberculosis and implications in vaccine development
Flynn, J. L. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.010 · Cited by 307
Self-citationManca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors
VAN DEN BROEK, M. F., MULLER, U., HUANG, S., ZINKERNAGEL, R. M., & AGUET, M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00090.x · Cited by 306
Black, G. F., Weir, R. E., Floyd, S., Bliss, L., Warndorff, D. K., Crampin, A. C., Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J. M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08353-8 · Cited by 306
Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., & Orme, I. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1322 · Cited by 304
Metadata
- Authors
- Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-12-01
- Volume
- 178
- Issue
- 6
- Pages
- 2249-2254
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2130046741
- Cited by
- 2,465
- References
- 26
- FWCI
- 27.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.